1. Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?

   • Sing Yu Moorcraft
   • Elizabeth C. Smyth
   • David Cunningham

   Review Article 18 March 2014 Pages: 1 - 10

2. A systematic review and meta-analysis of gastric cancer treatment in patients with positive peritoneal cytology

   • Carlos Suhady Cabalag
   • Steven Tuck Foo Chan
   • Cuong Phu Duong

   Review Article 03 June 2014 Pages: 11 - 22

   

3. Obesity and related risk factors in gastric cardia adenocarcinoma

   • Sidney Olefson
   • Steven F. Moss

   Review Article 11 September 2014 Pages: 23 - 32

   

4. Vascular Endothelial Growth Factor A Inhibition in Gastric Cancer

   • Do Joong Park
   • Nicholas J. Thomas
   • Sam S. Yoon

   Review Article 04 July 2014 Pages: 33 - 42

   

5. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer

   • Zheng Li
   • Huizi Lei
   • Jia Yu

   Original Article 31 January 2014 Pages: 43 - 54

   

6. Evaluation of the novel near-infrared fluorescence tracers pullulan polymer nanogel and indocyanine green/γ-glutamic acid complex for sentinel lymph node navigation surgery in large animal models

   • Seong-Ho Kong
   • Young-Woock Noh
   • Han-Kwang Yang

   Original Article 31 January 2014 Pages: 55 - 64

   

7. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer

   • Yukie Yoda
   • Hideyuki Takeshima
   • Toshikazu Ushijima

   Original Article 09 February 2014 Pages: 65 - 76

   

8. The course of gastric cancer following surgery is associated with genetic variations of the interleukin-1 receptor antagonist and interleukin-1β

   • Anke H. van der Ploeg
   • Oliver Kumpf
   • Lutz Hamann

   Original Article 21 February 2014 Pages: 77 - 83

9. Clinical significance of RacGAP1 expression at the invasive front of gastric cancer

   • Susumu Saigusa
   • Koji Tanaka
   • Masato Kusunoki

   Original Article 11 March 2014 Pages: 84 - 92

   

10. Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis

    • Qingfu Zhang
    • Jian Ming
    • Xueshan Qiu

    Original Article 22 February 2014 Pages: 93 - 99

    

11. Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases

    • Theresa L. A. Jeuck
    • Christian Wittekind

    Original Article 19 February 2014 Pages: 100 - 108

    

12. In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy

    • Tadanobu Shimura
    • Koji Tanaka
    • Masato Kusunoki

    Original Article 08 January 2014 Pages: 109 - 118

    

13. New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee

    • Tetsuji Sawada
    • Masakazu Yashiro
    • Yoshihiko Maehara

    Original Article Open access 01 February 2014 Pages: 119 - 128

    

14. Trends in the management of gastric cancer over a 32-year period: a French population-based study

    • Elodie Herbreteau
    • Valérie Jooste
    • Anne-Marie Bouvier

    Original Article 01 February 2014 Pages: 129 - 137

15. Preliminary study of surgical audit for overall survival following gastric cancer resection

    • Yoshio Haga
    • Koji Ikejiri
    • Hitoshi Takeuchi

    Original Article 06 February 2014 Pages: 138 - 146

    

16. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients

    • Koji Nakada
    • Masami Ikeda
    • Yasuhiro Kodera

    Original Article 11 February 2014 Pages: 147 - 158

    

17. Is a clear benefit in survival enough to modify patient access to the surgery service? A retrospective analysis in a cohort of gastric cancer patients

    • Mattia Altini
    • Elisa Carretta
    • Oriana Nanni

    Original Article 30 January 2014 Pages: 159 - 166

    

18. Erratum to: Is a clear benefit in survival enough to modify patient access to the surgery service? A retrospective analysis in a cohort of gastric cancer patients

    • Mattia Altini
    • Elisa Carretta
    • Oriana Nanni

    Erratum 24 April 2014 Pages: 167 - 167

19. Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

    • Lin Shen
    • Jin Li
    • Yongzhe Piao

    Original Article Open access 21 February 2014 Pages: 168 - 176

    

20. Laparoscopic completion total gastrectomy for remnant gastric cancer: a single-institution experience

    • Sang-Yong Son
    • Chang Min Lee
    • Hyung-Ho Kim

    Original Article 30 January 2014 Pages: 177 - 182

    

21. Totally laparoscopic pylorus-preserving gastrectomy for early gastric cancer in the middle stomach: technical report and surgical outcomes

    • Koshi Kumagai
    • Naoki Hiki
    • Toshiharu Yamaguchi

    Technical Note 31 January 2014 Pages: 183 - 187

    

22. A case of local recurrence and distant metastasis following curative endoscopic submucosal dissection of early gastric cancer

    • Seiichiro Abe
    • Ichiro Oda
    • Hitoshi Katai

    Case Report 31 January 2014 Pages: 188 - 192

    

23. Third international conference of the European Union Network of Excellence on gastric and esophagogastric junction cancer, Cologne, Germany, June 2012

    • Stefan Paul Moenig
    • Hans-Joachim Meyer
    • Arnulf Heinrich Hoelscher

    Meeting Report 13 February 2014 Pages: 193 - 199

24. Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse

    • Ferdinando C. M. Cananzi
    • Alberto Biondi
    • Vittorio Quagliuolo

    Letter to the Editor 29 March 2014 Pages: 200 - 201